VectorY Therapeutics has signed an agreement securing an exclusive option to assess Shape Therapeutics’ SHP-DB1 AAV capsid.

A tragic RSV vaccine trial in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in ...

American Indian and Alaska Native infants experience the highest rates of RSV-related hospitalization in the U.S., but a ...

Five key tech terms reshaping online shopping from mobile payments and instant delivery to social media commerce and ...

To solve a problem, scientists first need to see it clearly. Whether it’s a virus slipping past the immune system or plaques ...

The relationships we form as adults often echo those we had with our parents. According to attachment theory—one of the most ...

Shape Therapeutics Inc. could bring in as much as $1.2 billion in a new option and license deal with Vectory Therapeutics BV. It’s another collaboration for both companies that are known for working ...

At first, Ethel Branch thought her two-year-old son, Patro, had a cold or maybe the flu. Frantic, Branch rushed Patro to the ...

A new strain of canine distemper virus has been found in New Zealand fur seals (kekeno). Researchers are working to ...

Chinese fintech company WeBank's new headquarters is a naturally ventilated high-rise, with terraces, operable windows, and ...

Van Der Beek revealed he would not attend the "Dawson's Creek" reunion due to ongoing health struggles following his cancer ...

James Van Der Beek has been forced to drop out of the Dawson's Creek reunion on Monday (22,09.25) after being struck down ...